Lakeland Regional Health is participating in a national study to determine the effectiveness of ivermectin and two other prescription drugs in treating COVID-19 patients with mild to moderate symptoms, The Ledger reports. Qualifying patients are offered the chance to participate at the emergency room, and those who agree receive the drugs or a placebo at home. The study is being conducted by the National Institutes of Health, the Duke University Clinical Research Institute and the Vanderbilt University Medical Institute. | MORE: Read via MSN | Study overview in Raleigh News & Observer

Source: The Ledger

SEND CORRECTIONS, questions, feedback or news tips:

Barry Friedman founded in 2015 as the culmination of a career in print and digital journalism. Since 1982, he has used the tools of reporting, editing and content curation to help people in Lakeland understand their community better.

Join the Conversation

1 Comment

Leave a comment

Your Thoughts On This? (Comments are moderated; first and last name are required.)